CapsoVision, Inc

CV Nasdaq CIK: 0001378325

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 18805 COX AVENUE SUITE 250, SARATOGA, CA, 95070
Mailing Address 18805 COX AVENUE SUITE 250, SARATOGA, CA, 95070
Phone (408) 370-4790
Fiscal Year End 1231
EIN 203369494

Financial Overview

FY2025

$18.16M
Total Assets
$-1.03
EPS

Recent SEC Filings

Form Type Date Filed Document
3 Initial insider ownership report March 30, 2026 View on SEC
3 Initial insider ownership report March 26, 2026 View on SEC
10-K Annual financial report March 26, 2026 View on SEC
8-K Current report of material events March 26, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC

Annual Reports

10-K March 26, 2026
  • Successful IPO in July 2025 raising $65 million on Nasdaq (CV).
  • Innovative non-invasive 360-degree capsule endoscopy technology.
View Analysis

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.